Literature DB >> 16598318

Acinar cell ultrastructure after taurine treatment in rat acute necrotizing pancreatitis.

Yuksel Ates1, Mehmet R Mas, Nuket Mas, Ilker Tasci, Bilgin Comert, Ahmet T Isik, Nuran Yener.   

Abstract

OBJECTIVE: To evaluate the organelle-based changes in acinar cells in experimental acute necrotizing pancreatitis (ANP) after taurine treatment and the association of electron microscopic findings with histopathological changes and oxidative stress markers.
METHODS: The study was performed in February 2005 at Gulhane School of Medicine and Hecettepe University, Turkey. Forty-five rats were divided into 3 groups. Acute necrotizing pancreatitis was induced in groups II and III. Groups I and II were treated with saline and Group III with taurine 1000 mg/kg/day, i.p, for 48 hours. Histopathological and ultrastructural examinations were determined using one-way analysis of variance and Kruskal-Wallis tests.
RESULTS: Histopathologic findings improved significantly after taurine treatment. Degree of injury in rough and smooth endoplasmic reticulums, Golgi apparatus, mitochondria and nucleus of acinar cells also decreased with taurine in correlation with biochemical and histological results.
CONCLUSION: Taurine improves acinar cell organelle structure, and ultrastructural recovery in ANP reflects histological improvement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598318

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  2 in total

1.  Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis.

Authors:  Nuket Mas; Ilker Tasci; Bilgin Comert; Ramazan Ocal; Mehmet Refik Mas
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

2.  Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury.

Authors:  Ilker Tasci; Nuket Mas; Mehmet-Refik Mas; Murvet Tuncer; Bilgin Comert
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.